CXCR4 and prostate neoplasm: To confirm the role of CCL20 in the development and progression of CXCR4-overexpressing prostate tumors, we evaluated the effect of neutralizing antibodies to human CCL20 on the growth of CXCR4-overexpressing PC3 cells.